SYNGAP1 and Alzheimer disease: Taken together, our findings suggest that genetic DYRK1A manipulation modulates cognitive function through disease state–dependent mechanisms: restoring Aβ-suppressed CaMKIIα–CREB signaling under AD pathological conditions (5xFAD mice) or modulating SynGAP–P38 pathways under normal conditions (WT mice).